Power, sample size and adaptation considerations in the design of group sequential clinical trials (Q3429959): Difference between revisions
From MaRDI portal
Set profile property. |
Normalize DOI. |
||
| (One intermediate revision by one other user not shown) | |||
| Property / DOI | |||
| Property / DOI: 10.1093/biomet/91.3.507 / rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1093/biomet/91.3.507 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2315952772 / rank | |||
Normal rank | |||
| Property / DOI | |||
| Property / DOI: 10.1093/BIOMET/91.3.507 / rank | |||
Normal rank | |||
Latest revision as of 06:38, 21 December 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Power, sample size and adaptation considerations in the design of group sequential clinical trials |
scientific article |
Statements
Power, sample size and adaptation considerations in the design of group sequential clinical trials (English)
0 references
20 March 2007
0 references
futility boundary
0 references
group sequential test
0 references
information bound
0 references
